Lung function predicts mortality in people with serious mental illness: A 6-year follow-up study
Authors:
- Maria Jose Jaen-MorenoMJMaria Jose Jaen-Moreno
- David Laguna-MuñozDLDavid Laguna-Muñoz
- Gloria Isabel del PozoGPGloria Isabel del Pozo
- Cristina Camacho-RodríguezCCCristina Camacho-Rodríguez
- José Angel AlcaláJAJosé Angel Alcalá
- Micaela Reyes-LópezMRMicaela Reyes-López
- Ana Jiménez-PeinadoAJAna Jiménez-Peinado
Open Access
- 3 December 2025
- journal article
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 69 (1) , 1-24
Abstract
Background: The population with a serious mental illness (SMI) shows a high risk of premature mortality. Overexposed to multiple health risks throughout life, their main threat is physical illness, which starts earlier and is not diagnosed in time. Developing preventive actions is a public health priority. Methods: This longitudinal prospective study evaluated the predictive value of lung function on all-cause mortality in patients with schizophrenia (SCHIZ) or bipolar disorder. Patients aged 40–70 years, active smokers, and without preexisting respiratory disease underwent spirometry following American Thoracic Society/European Respiratory Society 2021 standards. Mortality data were collected through December 2022. Cox proportional hazards models and Kaplan–Meier survival curves analyzed the association between lung function, specifically forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), and mortality, adjusting for relevant confounders (age, gender, abdominal circumference, and comorbidities). Results: Of 107 participants (mean age 49.3 years, 63.3% male) with SMI (72% SCHIZ) and active smokers, 8 (7.5%) died during the 6-year follow-up (5 cardiovascular and 3 cancer). Mean z -scores were −1.41 (SD = 1.22) for FEV1 and −0.99 (SD = 1.16) for FVC. Lower FEV1 and FVC z -scores were significantly associated with increased mortality risk ( p = 0.002 and p = 0.009, respectively). Kaplan–Meier analysis confirmed this association for FEV1 ( p = 0.039) and FVC ( p = 0.007) but not for gender, comorbidities (hypertension, diabetes, and dyslipidemia), or FEV1/FVC. A multivariate Cox regression model, adjusting for age and abdominal circumference, confirmed the independent predictive value of lower FEV1 z -score for mortality (hazard regression = 0.473, 95% confidence interval: 0.220–0.979, p = 0.044). Conclusions: Poorer lung function, especially lower FEV1, was independently associated with all-cause mortality in SMI. Spirometry, an easily implementable technique, could help to detect at-risk individuals and favor prevention initiatives.Keywords
This publication has 48 references indexed in Scilit:
- Associations between expiratory spirometry parameters and limitations in daily life activities in patients with schizophreniaGeneral Hospital Psychiatry, 2014
- A Lower Level of Forced Expiratory Volume in 1 Second Is a Risk Factor for All-Cause and Cardiovascular Mortality in a Japanese Population: The Takahata StudyPLOS ONE, 2013
- Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depressionBipolar Disorders, 2009
- Mortality in COPD: role of comorbiditiesEuropean Respiratory Journal, 2006
- The cardiovascular and respiratory health of people with schizophreniaActa Psychiatrica Scandinavica, 2006
- Evaluación psicométrica comparativa de las versiones en español de 6, 17 y 21 ítems de la Escala de valoración de Hamilton para la evaluación de la depresiónMedicina Clinica, 2003
- Versión española de una escala de evaluación de la manía: validez y fiabilidad de la Escala de YoungMedicina Clinica, 2002
- Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population studyBMJ, 1996
- Psychometric properties of the Positive and Negative Syndrome Scale (PANSS) in schizophreniaPsychiatry Research, 1994
- Pulmonary Function: Relation to Aging, Cigarette Habit, and MortalityAnnals of Internal Medicine, 1975